Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	26.31	50.19	55.14	97.47	79.51	164.89
Short-Term Investments	230.73	285.88	202.96	326.68	446.73	285.61
Cash & Short-Term Investments	257.03	336.08	258.11	424.15	526.24	450.5
Cash Growth	-12.25%	30.21%	-39.15%	-19.40%	16.81%	50.48%
Accounts Receivable	64.94	84.76	69.02	51.13	52.75	139.15
Other Receivables	5.59	6.85	8.01	6.31	22.36	4.15
Receivables	70.53	91.61	77.03	57.45	75.11	143.3
Prepaid Expenses	4.98	5.1	6.63	7.74	6.81	4.24
Other Current Assets	121.44	117.7	11.81	18.5	19.71	13.92
Total Current Assets	454.77	550.49	353.57	507.85	627.87	611.96
Property, Plant & Equipment	120.44	117.85	111.72	95.62	98.92	71.16
Long-Term Investments	309.32	384.27	595.28	444.01	339.03	507.01
Goodwill	53.86	25.08	22.06	22.06	143.03	50.9
Other Intangible Assets	149.26	133.28	134.98	143.05	150.64	35.91
Long-Term Deferred Tax Assets	-	-	-	-	3.5	0.76
Other Long-Term Assets	1.58	2.56	2.37	22.75	23.05	1.02
Total Assets	1,089	1,214	1,220	1,235	1,386	1,279

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	15.56	18.65	18.36	15.36	23.09	20.49
Accrued Expenses	21.47	32.24	22.44	26.24	17.91	15.52
Short-Term Debt	-	-	-	-	15	21.28
Current Portion of Long-Term Debt	0.48	0.48	0.41	1.18	5.64	-
Current Portion of Leases	2.04	1.82	1.84	4.5	7.08	2.17
Current Income Taxes Payable	-	-	-	-	-	0.79
Current Unearned Revenue	3.4	3.64	2.23	2.87	3.2	14.57
Other Current Liabilities	28.81	28.15	27.61	22.86	16.2	30.49
Total Current Liabilities	71.76	84.97	72.9	73.02	88.11	105.31
Long-Term Debt	1.48	1.96	2.49	2.96	-	-
Long-Term Leases	5.61	3.78	4.48	7.91	10.61	6.74
Long-Term Deferred Tax Liabilities	6.89	6.94	6.37	7.96	-	-
Other Long-Term Liabilities	7.5	9.17	4.56	10.19	17.46	0.79
Total Liabilities	93.24	106.81	90.81	102.04	116.18	112.84

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	524.1	574.52	543.13	501.72	486.59	501.91
Retained Earnings	475.6	529.95	590.47	633.18	801	657.6
Comprehensive Income & Other	1.92	7.51	-0.37	1.21	-20.9	-0.76
Total Common Equity	1,002	1,112	1,133	1,136	1,267	1,159
Minority Interest	-5.63	-5.27	-4.07	-2.82	3.19	7.13
Shareholders' Equity	995.99	1,107	1,129	1,133	1,270	1,166
Total Liabilities & Equity	1,089	1,214	1,220	1,235	1,386	1,279

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	9.6	8.04	9.23	16.56	38.33	30.2
Net Cash (Debt)	541.75	697.31	819.23	831.17	814.56	905.35
Net Cash Growth	-29.60%	-14.88%	-1.44%	2.04%	-10.03%	117.48%
Net Cash Per Share	17.97	22.66	27.10	27.91	26.31	29.23
Filing Date Shares Outstanding	27.52	31.23	30.83	29.78	29.52	30.25
Total Common Shares Outstanding	27.52	31.08	30.84	29.65	29.44	30.16
Working Capital	383.01	465.52	280.67	434.83	539.77	506.65
Book Value Per Share	36.40	35.78	36.74	38.31	43.03	38.42
Tangible Book Value	798.5	953.63	976.2	970.99	973.02	1,072
Tangible Book Value Per Share	29.02	30.68	31.65	32.75	33.05	35.54
Land	17.35	17.35	17.35	8.8	7.5	7.5
Buildings	57.31	54.89	49.61	17.53	12.6	10.67
Machinery	85.9	80.71	76.07	73.65	71.97	51.22
Leasehold Improvements	4.5	4.47	3.32	11.22	11.8	4

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 15, 2026

Data Sources Report a data error